How To Label A Biosimilar? Copy The Reference Product, FDA Told Sandoz

But agency had to weigh how presentation differences between Sandoz’s Zarxio and Amgen’s Neupogen, as well as Neupogen-specific safety information, should be reflected in the biosimilar’s labeling.

More from United States

More from North America